What Is PT-141?
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide derived from Melanotan II, itself a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH). With a molecular weight of 1,025.18 Da, PT-141 acts as a non-selective agonist at melanocortin receptors — particularly the MC3R and MC4R subtypes — making it a compound of significant research interest in the neuroscience of motivated behavior, autonomic nervous system function, and central nervous system signaling.
PT-141 was developed as a research compound specifically to investigate central melanocortin receptor pathways. Unlike peripherally-acting compounds, PT-141 crosses the blood-brain barrier, enabling direct investigation of central melanocortin receptor function — a distinction that makes it mechanistically unique among peptide research tools.
The Melanocortin System
Understanding PT-141 requires understanding the melanocortin system it targets. Melanocortin receptors (MC1R through MC5R) are G protein-coupled receptors distributed throughout the body and brain. They are activated by endogenous melanocortin peptides derived from pro-opiomelanocortin (POMC) — including α-MSH, β-MSH, and ACTH.
The melanocortin system regulates a remarkably diverse array of physiological processes including pigmentation (MC1R), adrenal steroidogenesis (MC2R), energy homeostasis and autonomic function (MC3R, MC4R), and exocrine gland function (MC5R). The central melanocortin receptors — MC3R and MC4R — are expressed throughout the hypothalamus, limbic system, and brainstem, where they modulate energy balance, autonomic outflow, and behavioral circuits.
Mechanism of Action
MC3R and MC4R Agonism
PT-141 binds with high affinity to MC3R and MC4R, activating Gs-protein coupled signaling that increases intracellular cAMP. MC4R in particular is densely expressed in the paraventricular nucleus of the hypothalamus and in spinal cord circuits that regulate autonomic nervous system outflow. MC3R expression in the hypothalamus and limbic system contributes to energy homeostasis regulation and motivational circuitry.
Central vs. Peripheral Action
A critical mechanistic distinction between PT-141 and its predecessor Melanotan II is PT-141’s blood-brain barrier permeability. Melanotan II acts on both peripheral and central melanocortin receptors; PT-141’s pharmacokinetic profile allows investigation of centrally-mediated melanocortin effects in research designs where peripheral MC receptor activation is a confound.
Autonomic Nervous System Modulation
MC4R activation in the spinal cord and brainstem influences autonomic nervous system outflow. Research has investigated how PT-141-induced MC4R activation in these regions affects sympathetic and parasympathetic tone, cardiovascular parameters, and visceral autonomic responses.
Research Applications
Sexual Function and Motivational Behavior Research
PT-141 was originally developed for research into melanocortin pathways underlying motivated behavior. The MC4R pathway in the hypothalamus and limbic system plays established roles in behavioral motivation circuits, and PT-141 has been extensively used as a research tool to investigate the neurobiological mechanisms underlying these behaviors in animal models.
The compound activates pro-erectile circuits in the spinal cord and hypothalamus through MC4R pathways — research in rodent models demonstrated that melanocortin receptor activation in specific brain regions triggers autonomic responses associated with sexual arousal independently of hormonal status. This central mechanism distinguishes the melanocortin pathway from peripheral vascular mechanisms and makes PT-141 a tool for dissecting the neuroscience of motivated behavior.
Energy Homeostasis Research
MC3R and MC4R are key regulators of energy homeostasis in the hypothalamus. PT-141’s agonism at these receptors has been studied in energy balance research — examining its effects on food intake, energy expenditure, and adiposity in relevant animal models. The MC4R pathway in the hypothalamus is a well-validated target in obesity research, and PT-141 provides a tool for investigating its role in appetite regulation and metabolic rate.
Cardiovascular Research
The autonomic effects of central melanocortin receptor activation have cardiovascular implications. Research has investigated PT-141’s effects on heart rate, blood pressure, and vascular tone through its central MC4R agonism. The compound’s influence on sympathetic outflow from the brainstem and spinal cord melanocortin circuits has been examined in cardiovascular physiology models.
Neuroinflammation Research
Melanocortin receptors, particularly MC1R and MC3R, have been implicated in neuroinflammatory signaling. Research has investigated α-MSH derivatives including PT-141 in models of neuroinflammation, examining their effects on microglial activation, pro-inflammatory cytokine production in the CNS, and neuroprotection against inflammatory injury.
Melanocortin System Mapping
PT-141 has been used as a pharmacological tool for mapping melanocortin receptor distribution and function across the nervous system. By administering PT-141 with or without selective MC receptor antagonists, researchers can identify which behavioral and physiological effects are mediated through specific receptor subtypes in specific brain regions.
Comparison with Melanotan II
PT-141 and Melanotan II are closely related compounds with overlapping but distinct research profiles. Melanotan II is a non-selective melanocortin agonist with higher potency at MC1R (affecting pigmentation) and MC5R in addition to MC3R and MC4R. PT-141 was designed to retain MC3R/MC4R activity while reducing off-target melanocortin receptor effects, making it a more selective research tool for central melanocortin pathway investigation.
For research designs specifically investigating central MC3R/MC4R pathways without confounding pigmentation effects (MC1R) or exocrine effects (MC5R), PT-141 is the more appropriate compound.
Formulation and Storage
PT-141 is available as a lyophilized powder. Reconstitution with sterile or bacteriostatic water is standard for research applications. The cyclic peptide structure provides relatively good stability compared to linear peptides of similar size, but standard storage protocols apply — lyophilized at -20°C, reconstituted solutions at 2–8°C protected from light.
Research-grade purity should be confirmed at ≥99% by HPLC with mass spectrometry verification of the 1,025.18 Da molecular weight and correct cyclic structure.
Research Outlook
PT-141 remains an active research compound in 2026, particularly in neuroscience research investigating central melanocortin receptor pathways, motivational behavior circuits, energy homeostasis regulation, and autonomic nervous system function. Its blood-brain barrier permeability and relative MC3R/MC4R selectivity make it a valuable pharmacological tool for research designs requiring central melanocortin pathway engagement without the broader receptor profile of Melanotan II.
Melanocortin receptor pathway research
All products sold by AminoForge are intended exclusively for laboratory and research purposes. Not for human or veterinary consumption. Researchers are responsible for compliance with all applicable laws and regulations governing research compound use in their jurisdiction.